169 related articles for article (PubMed ID: 17371269)
1. Unusual aspects of the polyamine transport system affect the design of strategies for use of polyamine analogues in chemotherapy.
Mitchell JL; Thane TK; Sequeira JM; Thokala R
Biochem Soc Trans; 2007 Apr; 35(Pt 2):318-21. PubMed ID: 17371269
[TBL] [Abstract][Full Text] [Related]
2. Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs.
Mitchell JL; Thane TK; Sequeira JM; Marton LJ; Thokala R
Amino Acids; 2007 Aug; 33(2):291-7. PubMed ID: 17410332
[TBL] [Abstract][Full Text] [Related]
3. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
4. Antizyme induction by polyamine analogues as a factor of cell growth inhibition.
Mitchell JL; Leyser A; Holtorff MS; Bates JS; Frydman B; Valasinas AL; Reddy VK; Marton LJ
Biochem J; 2002 Sep; 366(Pt 2):663-71. PubMed ID: 11972449
[TBL] [Abstract][Full Text] [Related]
5. Divergent regulation of the key enzymes of polyamine metabolism by chiral alpha-methylated polyamine analogues.
Hyvönen MT; Howard MT; Anderson CB; Grigorenko N; Khomutov AR; Vepsäläinen J; Alhonen L; Jänne J; Keinänen TA
Biochem J; 2009 Aug; 422(2):321-8. PubMed ID: 19522702
[TBL] [Abstract][Full Text] [Related]
6. Properties of a polyamine transporter regulated by antizyme.
Sakata K; Kashiwagi K; Igarashi K
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):297-303. PubMed ID: 10727431
[TBL] [Abstract][Full Text] [Related]
7. Polyamines: fundamental characters in chemistry and biology.
Agostinelli E; Marques MP; Calheiros R; Gil FP; Tempera G; Viceconte N; Battaglia V; Grancara S; Toninello A
Amino Acids; 2010 Feb; 38(2):393-403. PubMed ID: 20013011
[TBL] [Abstract][Full Text] [Related]
8. Antizyme induction mediates feedback limitation of the incorporation of specific polyamine analogues in tissue culture.
Mitchell JL; Simkus CL; Thane TK; Tokarz P; Bonar MM; Frydman B; Valasinas AL; Reddy VK; Marton LJ
Biochem J; 2004 Dec; 384(Pt 2):271-9. PubMed ID: 15315476
[TBL] [Abstract][Full Text] [Related]
9. Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ODC activity, and deplete cellular polyamines.
Petros LM; Graminski GF; Robinson S; Burns MR; Kisiel N; Gesteland RF; Atkins JF; Kramer DL; Howard MT; Weeks RS
J Biochem; 2006 Nov; 140(5):657-66. PubMed ID: 16998202
[TBL] [Abstract][Full Text] [Related]
10. Comparative molecular field analysis-based predictive model of structure-function relationships of polyamine transport inhibitors in L1210 cells.
Li Y; MacKerell AD; Egorin MJ; Ballesteros MF; Rosen DM; Wu YY; Blamble DA; Callery PS
Cancer Res; 1997 Jan; 57(2):234-9. PubMed ID: 9000561
[TBL] [Abstract][Full Text] [Related]
11. Identification of regulatory region of antizyme necessary for the negative regulation of polyamine transport.
Sakata K; Fukuchi-Shimogori T; Kashiwagi K; Igarashi K
Biochem Biophys Res Commun; 1997 Sep; 238(2):415-9. PubMed ID: 9299523
[TBL] [Abstract][Full Text] [Related]
12. The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines.
Stanic' I; Facchini A; Borzì RM; Stefanelli C; Flamigni F
J Cell Physiol; 2009 Apr; 219(1):109-16. PubMed ID: 19097065
[TBL] [Abstract][Full Text] [Related]
13. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
Keren-Paz A; Bercovich Z; Kahana C
Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
[TBL] [Abstract][Full Text] [Related]
14. Polyamine modulation of iron uptake in CHO cells.
Gaboriau F; Kreder A; Clavreul N; Moulinoux JP; Delcros JG; Lescoat G
Biochem Pharmacol; 2004 May; 67(9):1629-37. PubMed ID: 15081862
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy.
Seiler N
Pharmacol Ther; 2005 Jul; 107(1):99-119. PubMed ID: 15963353
[TBL] [Abstract][Full Text] [Related]
16. Design and testing of novel cytotoxic polyamine analogues.
Basu HS; Marton LJ; Pellarin M; Deen DF; McManis JS; Liu CZ; Bergeron RJ; Feuerstein BG
Cancer Res; 1994 Dec; 54(23):6210-4. PubMed ID: 7954468
[TBL] [Abstract][Full Text] [Related]
17. [Methylated analogues of spermine and spermidine as tools to investigate cellular functions of polyamines and the enzymes of their metabolism].
Khomutov AR; Keinanen TA; Grigorenko NA; Hyvonen MT; Uimari A; Pietila M; Cerrada-Gimenez M; Simonian AR; Khomutov MA; Verspalainen J; Alhonen L; Janne J
Mol Biol (Mosk); 2009; 43(2):274-85. PubMed ID: 19425496
[TBL] [Abstract][Full Text] [Related]
18. Polyamine analogues - an update.
Wallace HM; Niiranen K
Amino Acids; 2007 Aug; 33(2):261-5. PubMed ID: 17443267
[TBL] [Abstract][Full Text] [Related]
19. Antizyme-dependent and -independent mechanisms are responsible for increased spermidine transport in amino acid-restricted human cancer cells.
Aubel C; Chabanon H; Persson L; Thiman L; Ferrara M; Brachet P
Biochem Biophys Res Commun; 1999 Mar; 256(3):646-51. PubMed ID: 10080953
[TBL] [Abstract][Full Text] [Related]
20. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives.
Seiler N
Curr Drug Targets; 2003 Oct; 4(7):565-85. PubMed ID: 14535655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
